Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

D2 dissection for gastric cancer

J S Lee1, H O Douglass

  • 1Division of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

Surgical Oncology
|October 17, 1998
PubMed
Summary

Theodore Billroth

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Is glucagonoma of the pancreas a curable disease?

International journal of pancreatology : official journal of the International Association of Pancreatology·2002
Same author

Unexpected cyanosis in the surgical patient.

Surgical endoscopy·2001
Same author

A patient's right to truly informed consent.

Archives of surgery (Chicago, Ill. : 1960)·2000
Same author

Outcome of patients with proximal gastric cancer depends on extent of resection and number of resected lymph nodes.

Annals of surgical oncology·2000
Same author

Results from National Surgical Adjuvant Breast and Bowel project colon cancer trials.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Same author

Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the Eastern Cooperative Oncology Group.

International journal of radiation oncology, biology, physics·1998

Area of Science:

  • Surgical Oncology
  • Gastroenterology

Background:

  • Gastric cancer remains a significant global health challenge, particularly in certain regions.
  • Despite advancements, gastric cancer has a high mortality rate, with limited treatment options historically.
  • The Japanese Research Society for Gastric Cancer established lymph node classification and dissection levels (D1-D4).

Purpose of the Study:

  • To evaluate the effectiveness of different lymph node dissection levels in gastric cancer surgery.
  • To determine the optimal extent of lymphadenectomy for improving patient outcomes.

Main Methods:

  • Review of retrospective series comparing D1 and D2 lymph node dissections.
  • Analysis of large international trials assessing D1 vs. D2 dissection outcomes.
  • Examination of tumor invasion depth and its correlation with lymph node metastasis.

Main Results:

  • D2 lymph node dissection is associated with improved staging and survival compared to D1.
  • Tumor penetration beyond the serosa (T3) significantly increases the likelihood of N2 lymph node metastasis.
  • Trials show comparable morbidity and mortality between D1 and D2 dissections.

Conclusions:

  • D2 lymph node dissection is crucial for accurate staging and improved survival in gastric cancer patients.
  • Current adjuvant therapies like chemotherapy have not demonstrated reproducible survival benefits.
  • Advancements in surgical techniques and anesthesia have improved survival, with D2 dissection being a key factor.

Related Experiment Videos